133 related articles for article (PubMed ID: 15865929)
1. Prospective therapeutic applications of p53 inhibitors.
Gudkov AV; Komarova EA
Biochem Biophys Res Commun; 2005 Jun; 331(3):726-36. PubMed ID: 15865929
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation.
Strom E; Sathe S; Komarov PG; Chernova OB; Pavlovska I; Shyshynova I; Bosykh DA; Burdelya LG; Macklis RM; Skaliter R; Komarova EA; Gudkov AV
Nat Chem Biol; 2006 Sep; 2(9):474-9. PubMed ID: 16862141
[TBL] [Abstract][Full Text] [Related]
3. [A chemical inhibitor of p53 that protects mice from the side effects of cancer treatment].
Stadler P; Grosu AL; Molls M
Strahlenther Onkol; 2000 Feb; 176(2):98. PubMed ID: 10697660
[No Abstract] [Full Text] [Related]
4. Inhibition of p53 response in tumor stroma improves efficacy of anticancer treatment by increasing antiangiogenic effects of chemotherapy and radiotherapy in mice.
Burdelya LG; Komarova EA; Hill JE; Browder T; Tararova ND; Mavrakis L; DiCorleto PE; Folkman J; Gudkov AV
Cancer Res; 2006 Oct; 66(19):9356-61. PubMed ID: 17018587
[TBL] [Abstract][Full Text] [Related]
5. Effects of p53 inhibitor on survival and death of cells subjected to oxidative stress.
Strosznajder RP; Jesko H; Banasik M; Tanaka S
J Physiol Pharmacol; 2005 Sep; 56 Suppl 4():215-21. PubMed ID: 16204796
[TBL] [Abstract][Full Text] [Related]
6. Pifithrin-α provides neuroprotective effects at the level of mitochondria independently of p53 inhibition.
Neitemeier S; Ganjam GK; Diemert S; Culmsee C
Apoptosis; 2014 Dec; 19(12):1665-77. PubMed ID: 25343947
[TBL] [Abstract][Full Text] [Related]
7. A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy.
Komarov PG; Komarova EA; Kondratov RV; Christov-Tselkov K; Coon JS; Chernov MV; Gudkov AV
Science; 1999 Sep; 285(5434):1733-7. PubMed ID: 10481009
[TBL] [Abstract][Full Text] [Related]
8. The role of p53-induced apoptosis in cerebral ischemia: effects of the p53 inhibitor pifithrin alpha.
Leker RR; Aharonowiz M; Greig NH; Ovadia H
Exp Neurol; 2004 Jun; 187(2):478-86. PubMed ID: 15144874
[TBL] [Abstract][Full Text] [Related]
9. Imino-tetrahydro-benzothiazole derivatives as p53 inhibitors: discovery of a highly potent in vivo inhibitor and its action mechanism.
Pietrancosta N; Moumen A; Dono R; Lingor P; Planchamp V; Lamballe F; Bähr M; Kraus JL; Maina F
J Med Chem; 2006 Jun; 49(12):3645-52. PubMed ID: 16759106
[TBL] [Abstract][Full Text] [Related]
10. Suppression of p53: a new approach to overcome side effects of antitumor therapy.
Komarova EA; Gudkov AV
Biochemistry (Mosc); 2000 Jan; 65(1):41-8. PubMed ID: 10702639
[TBL] [Abstract][Full Text] [Related]
11. Pifithrin-alpha, an inhibitor of p53, enhances the genetic instability induced by etoposide (VP16) in human lymphoblastoid cells treated in vitro.
Bassi L; Carloni M; Fonti E; Palma de la Peña N; Meschini R; Palitti F
Mutat Res; 2002 Feb; 499(2):163-76. PubMed ID: 11827710
[TBL] [Abstract][Full Text] [Related]
12. Pifithrin-alpha promotes p53-mediated apoptosis in JB6 cells.
Kaji A; Zhang Y; Nomura M; Bode AM; Ma WY; She QB; Dong Z
Mol Carcinog; 2003 Jul; 37(3):138-48. PubMed ID: 12884365
[TBL] [Abstract][Full Text] [Related]
13. The p53 inhibitor pifithrin-alpha is a potent agonist of the aryl hydrocarbon receptor.
Hoagland MS; Hoagland EM; Swanson HI
J Pharmacol Exp Ther; 2005 Aug; 314(2):603-10. PubMed ID: 15843497
[TBL] [Abstract][Full Text] [Related]
14. The p53-inhibitor pifithrin-alpha inhibits firefly luciferase activity in vivo and in vitro.
Rocha S; Campbell KJ; Roche KC; Perkins ND
BMC Mol Biol; 2003 Sep; 4():9. PubMed ID: 12967348
[TBL] [Abstract][Full Text] [Related]
15. Differential protection and transactivation of P53, P21, Bcl2, PCNA, cyclin G, and MDM2 genes in rat liver and the HepG2 cell line upon exposure to pifithrin.
Farah IO; Begum RA; Ishaque AB
Biomed Sci Instrum; 2007; 43():116-21. PubMed ID: 17487067
[TBL] [Abstract][Full Text] [Related]
16. Oxidative stress induces p53-mediated apoptosis in glia: p53 transcription-independent way to die.
Bonini P; Cicconi S; Cardinale A; Vitale C; Serafino AL; Ciotti MT; Marlier LN
J Neurosci Res; 2004 Jan; 75(1):83-95. PubMed ID: 14689451
[TBL] [Abstract][Full Text] [Related]
17. p53 inhibitors preserve dopamine neurons and motor function in experimental parkinsonism.
Duan W; Zhu X; Ladenheim B; Yu QS; Guo Z; Oyler J; Cutler RG; Cadet JL; Greig NH; Mattson MP
Ann Neurol; 2002 Nov; 52(5):597-606. PubMed ID: 12402257
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death.
Schäfer T; Scheuer C; Roemer K; Menger MD; Vollmar B
FASEB J; 2003 Apr; 17(6):660-7. PubMed ID: 12665479
[TBL] [Abstract][Full Text] [Related]
19. Pifithrin-α as a potential cytoprotective agent in radiotherapy: protection of normal tissue without decreasing therapeutic efficacy in glioma cells.
Sinn B; Schulze J; Schroeder G; Konschak R; Freyer D; Budach V; Tinhofer I
Radiat Res; 2010 Nov; 174(5):601-10. PubMed ID: 20718603
[TBL] [Abstract][Full Text] [Related]
20. Role of p53 in cisplatin-induced tubular cell apoptosis: dependence on p53 transcriptional activity.
Jiang M; Yi X; Hsu S; Wang CY; Dong Z
Am J Physiol Renal Physiol; 2004 Dec; 287(6):F1140-7. PubMed ID: 15315938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
